{"id": "1365014578875289608", "creation": 1614279811.0, "user_id": "1233901069366771712", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 2, "quote_count": 0}}, "text": ".@Novavax,  Late to the Game, Faces an Uphill Battle for #COVID19 #vaccine Success\n\n$NVAX success depends on manufacturing &amp; licensee deals with Baxter, Serum Inst.of India (SII), Takaeda and Canada's NCR.\n\n$BAX $TAK $INO $ARCT #investing #daytrading\n\nhttps://t.co/9CkwjI6JbV", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#INVESTING", "#DAYTRADING"]}